Michael C. Levin

3.3k total citations
89 papers, 2.5k citations indexed

About

Michael C. Levin is a scholar working on Molecular Biology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Michael C. Levin has authored 89 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 33 papers in Immunology and 23 papers in Pathology and Forensic Medicine. Recurrent topics in Michael C. Levin's work include T-cell and Retrovirus Studies (26 papers), Multiple Sclerosis Research Studies (22 papers) and RNA Research and Splicing (21 papers). Michael C. Levin is often cited by papers focused on T-cell and Retrovirus Studies (26 papers), Multiple Sclerosis Research Studies (22 papers) and RNA Research and Splicing (21 papers). Michael C. Levin collaborates with scholars based in United States, Canada and United Kingdom. Michael C. Levin's co-authors include Hannah E. Salapa, Steven Jacobson, Paul E. Sawchenko, Yvette Morcos, Patricia A. Thibault, Lidia A. Gardner, Joseph-Patrick W. E. Clarke, Tanya Lehky, Stephen R. Bloom and J. M. Polak and has published in prestigious journals such as New England Journal of Medicine, Nature Medicine and Nature Communications.

In The Last Decade

Michael C. Levin

86 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael C. Levin United States 26 840 804 416 396 354 89 2.5k
O. Lyon‐Caen France 31 377 0.4× 877 1.1× 1.2k 2.9× 173 0.4× 71 0.2× 99 3.9k
Unsong Oh United States 24 722 0.9× 410 0.5× 293 0.7× 29 0.1× 186 0.5× 46 1.8k
David H. Mattson United States 23 582 0.7× 255 0.3× 674 1.6× 71 0.2× 99 0.3× 40 1.8k
Vincent Van Pesch Belgium 25 442 0.5× 448 0.6× 648 1.6× 186 0.5× 39 0.1× 94 1.9k
Anders Svenningsson Sweden 38 1.2k 1.4× 862 1.1× 3.4k 8.2× 136 0.3× 58 0.2× 110 5.4k
S L Hauser United States 15 764 0.9× 288 0.4× 946 2.3× 76 0.2× 44 0.1× 20 2.0k
G Schaison France 36 559 0.7× 1.1k 1.4× 242 0.6× 68 0.2× 98 0.3× 160 4.3k
Christoph M. Bamberger Germany 27 793 0.9× 750 0.9× 135 0.3× 86 0.2× 79 0.2× 58 3.9k
Manabu Wada Japan 29 182 0.2× 1.2k 1.5× 99 0.2× 230 0.6× 13 0.0× 101 3.1k
Masaaki Niino Japan 30 1.3k 1.6× 661 0.8× 1.7k 4.1× 75 0.2× 15 0.0× 140 3.3k

Countries citing papers authored by Michael C. Levin

Since Specialization
Citations

This map shows the geographic impact of Michael C. Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael C. Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael C. Levin more than expected).

Fields of papers citing papers by Michael C. Levin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael C. Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael C. Levin. The network helps show where Michael C. Levin may publish in the future.

Co-authorship network of co-authors of Michael C. Levin

This figure shows the co-authorship network connecting the top 25 collaborators of Michael C. Levin. A scholar is included among the top collaborators of Michael C. Levin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael C. Levin. Michael C. Levin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Clarke, Joseph-Patrick W. E., Patricia A. Thibault, Hannah E. Salapa, et al.. (2023). Sequence- and structure-specific RNA oligonucleotide binding attenuates heterogeneous nuclear ribonucleoprotein A1 dysfunction. Frontiers in Molecular Biosciences. 10. 1178439–1178439. 3 indexed citations
5.
Baldwin, Bruce A., Janice J. Eng, Prosanta Mondal, et al.. (2023). Task-oriented exercise effects on walking and corticospinal excitability in multiple sclerosis: protocol for a randomized controlled trial. BMC Sports Science Medicine and Rehabilitation. 15(1). 175–175.
6.
Salapa, Hannah E., et al.. (2022). Autoimmunity to a ribonucleoprotein drives neuron loss in multiple sclerosis models. Neurobiology of Disease. 170. 105775–105775. 10 indexed citations
7.
Salapa, Hannah E., et al.. (2021). Pro-Inflammatory Cytokines and Antibodies Induce hnRNP A1 Dysfunction in Mouse Primary Cortical Neurons. Brain Sciences. 11(10). 1282–1282. 9 indexed citations
8.
Freedman, Mark S., Virginia Devonshire, Pierre Duquette, et al.. (2020). Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group Recommendations. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 47(4). 437–455. 72 indexed citations
9.
10.
11.
Gardner, Lidia A., Hannah E. Salapa, Stephen J. Lalor, et al.. (2016). Antibodies to the RNA-binding protein hnRNP A1 contribute to neurodegeneration in a model of central nervous system autoimmune inflammatory disease. Journal of Neuroinflammation. 13(1). 178–178. 27 indexed citations
12.
13.
Lee, Sang‐Min, Yoojin Shin, Daniel Clark, Eduardo Gotuzzo, & Michael C. Levin. (2012). Cross-Reactive Antibodies to Target Proteins are Dependent upon Oligomannose Glycosylated Epitopes in HTLV-1 Associated Neurological Disease. Journal of Clinical Immunology. 32(4). 736–745. 3 indexed citations
14.
Lee, Sang‐Min, et al.. (2008). Post-translational glycosylation of target proteins implicate molecular mimicry in the pathogenesis of HTLV-1 associated neurological disease. Journal of Neuroimmunology. 204(1-2). 140–148. 14 indexed citations
15.
Khan, Raja B., Tulio E. Bertorini, & Michael C. Levin. (2001). HTLV-1 and Its Neurological Complications. The Neurologist. 7(5). 271–278. 14 indexed citations
16.
Soldan, Samantha S., Michael D. Graf, Allen Waziri, et al.. (1999). HTLV‐I/II Seroindeterminate Western Blot Reactivity in a Cohort of Patients with Neurological Disease. The Journal of Infectious Diseases. 180(3). 685–694. 15 indexed citations
17.
Lehky, Tanya, Michael C. Levin, Ryuji Kubota, et al.. (1998). Reduction in HTLV‐I proviral load and spontaneous lymphoproliferation in HTLV‐I–associated myelopathy/tropical spastic paraparesis patients treated with humanized anti‐tac. Annals of Neurology. 44(6). 942–947. 59 indexed citations
18.
19.
Harden, A., et al.. (1991). EEG Features and Their Evolution in the Acute Phase of Haemorrhagic Shock and Encephalopathy Syndrome. Neuropediatrics. 22(4). 194–197. 11 indexed citations
20.
Santner, Steven J., Michael C. Levin, & Richard J. Santen. (1990). Estrone sulfate stimulates growth of nitrosomethylurea‐induced breast carcinoma in vivo in the rat. International Journal of Cancer. 46(1). 73–78. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by O. Lyon‐Caen Breakdown of academic impact, for papers by Unsong Oh Breakdown of academic impact, for papers by David H. Mattson Breakdown of academic impact, for papers by Vincent Van Pesch Breakdown of academic impact, for papers by Anders Svenningsson Breakdown of academic impact, for papers by S L Hauser Breakdown of academic impact, for papers by G Schaison Breakdown of academic impact, for papers by Christoph M. Bamberger Breakdown of academic impact, for papers by Manabu Wada Breakdown of academic impact, for papers by Masaaki Niino
Rankless by CCL
2026